Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
MSC On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
Venture
All times are local (Market data is delayed by at least 15 minutes).

meridex software corp (MSC) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MERIDEX SOFTWARE CORP (MSC)

Related News

No related news articles were found.

meridex software corp (MSC) Related Businessweek News

No Related Businessweek News Found

meridex software corp (MSC) Details

InMed Pharmaceuticals Inc., a biopharmaceutical company, engages in the development of cannabis-based botanical and non-botanical therapies. Its Drug Discovery and Development division utilizes its proprietary Cannabinoid Drug Design Platform to identify new bioactive compounds within the marijuana plant that interact with various gene responsible for specific diseases. The company’s Cultivation and Breeding division researches and develops individual strains and clones for producing the raw material bases for future pharmaceutical research. It focuses on various therapeutic areas, including glaucoma, inflammation/pain/arthritis, Huntington's and Epilepsy diseases, diabetes, obesity, cancer, and angiogenesis. InMed Pharmaceuticals Inc. has strategic collaboration with the University of Debrecen, Hungary, to develop novel phytocannabinoid-based therapies to treat ocular allergic symptoms. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. is based in Vancouver, Canada.

meridex software corp (MSC) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: --
Chief Financial officer
Total Annual Compensation: C$12.9K
Compensation as of Fiscal Year 2013.

meridex software corp (MSC) Key Developments

InMed Pharmaceuticals Inc. Presents at Equities.com Small-Cap Stars Spring Conference, Jun-10-2015

InMed Pharmaceuticals Inc. Presents at Equities.com Small-Cap Stars Spring Conference, Jun-10-2015 . Venue: Convene Times Square, New York, New York, United States.

InMed Pharmaceuticals Inc. Announces Board Appointments

InMed Pharmaceuticals Inc. announced the appointment of Paul C. Anderson, Ph.D., to its Scientific Advisory Board.  Dr. Anderson is a pharma industry veteran who brings significant drug discovery and development expertise to InMed. Dr. Anderson is a synthetic organic chemist by training with more than 30 years of experience in pharmaceutical research and development. Following postdoctoral studies in bioorganic chemistry at the University of Cambridge, In addition, InMed announced the appointment of Dr. Sazzad Hossain to its Board of Directors. Dr. Hossain is the current Chief Scientific Officer of InMed and a co-founder of the company.

InMed Pharmaceuticals Initiates Discovery & Pre-clinical Work on Orofacial Pain

InMed Pharmaceuticals Inc. announced that it has initiated a program to identify and evaluate cannabinoid compounds for the treatment of chronic orofacial pain. Initial drug discovery and preclinical development is currently underway in collaboration with members of the Faculty of Pharmaceutical Sciences at the University of British Columbia. The work is being funded by a grant from Mitacs, a leading Canadian organization that accelerates innovative projects through strategic academic and industry collaboration.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSC:CN C$0.00 CAD 0.00

MSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MSC.
View Industry Companies
 

Industry Analysis

MSC

Industry Average

Valuation MSC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 5.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERIDEX SOFTWARE CORP, please visit www.cannabis-tech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.